How is disease progress in Friedreich's ataxia best measured? A study of four rating scales.
about
Antioxidants and other pharmacological treatments for Friedreich ataxiaDyclonine rescues frataxin deficiency in animal models and buccal cells of patients with Friedreich's ataxia.Combined therapy with idebenone and deferiprone in patients with Friedreich's ataxia.Assessment of neurological efficacy of idebenone in pediatric patients with Friedreich's ataxia: data from a 6-month controlled study followed by a 12-month open-label extension study.(1)H MR spectroscopy in Friedreich's ataxia and ataxia with oculomotor apraxia type 2.Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design.A randomized trial of oral betamethasone to reduce ataxia symptoms in ataxia telangiectasia.Dysphagia and swallowing-related quality of life in Friedreich ataxia.Clinical experience with high-dose idebenone in Friedreich ataxia.Ophthalmic features of Friedreich ataxia.Rating disease progression of Friedreich's ataxia by the International Cooperative Ataxia Rating Scale: analysis of a 603-patient database.Friedreich ataxia clinical outcome measures: natural history evaluation in 410 participantsAtaxia rating scales--psychometric profiles, natural history and their application in clinical trials.A review of Friedreich ataxia clinical trial results.Clinical features of Friedreich's ataxia: classical and atypical phenotypes.Monitoring progression in Friedreich ataxia (FRDA): the use of clinical scales.Milestones in Friedreich ataxia: more than a century and still learning.Annual change in Friedreich's ataxia evaluated by the Scale for the Assessment and Rating of Ataxia (SARA) is independent of disease severity.Nasality in Friedreich ataxia.Spinal cord atrophy correlates with disability in Friedreich's ataxia.Neurobehavioral deficits in the KIKO mouse model of Friedreich's ataxia.Quantitative assessment of the evolution of cerebellar signs in spinocerebellar ataxias.Emerging therapeutics for the treatment of Friedreich’s ataxiaIdebenone in Friedreich's ataxiaDentate nuclei T2 relaxometry is a reliable neuroimaging marker in Friedreich's ataxiaAn open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels
P2860
Q24240370-DFD8E9AF-F615-41EC-B10D-54D18F105518Q30602174-194750A8-4D8B-4491-8626-AC336F18248AQ33701891-74873789-3DC4-4928-B99D-BA5F0FAC99CBQ33968480-787D1497-EAA4-4780-8156-C842FA955040Q34172946-96420B19-FEA1-4732-B010-83E4558220ADQ34197370-E3371C0E-E373-401C-AE46-F352089F109FQ34296348-4D8D28F6-A28D-42AB-9573-16FE6A6C1C86Q34394515-FF3B6015-3658-4B79-A8BB-BD92CCD64FC4Q34778763-25E1A959-67A1-4C5F-8525-2FFB8CF2B96BQ35737384-96C3AD73-D0D5-4D32-8A5F-6551A59BEE6EQ36760861-91C87BED-B9E0-4D07-B27F-8B688D7A3BC3Q36907355-360B22AE-E797-46C5-9AEB-477F3CCA1D16Q37941519-CBFF89F2-EC73-497C-B9F6-565CCC956025Q38038592-8D7D2945-8801-480E-BB3D-7CA13E839EC3Q38121948-4CA56059-54B1-442A-A511-C8D7C8328807Q38121949-0F43B663-7424-4F8D-93FD-3A2B27F24BE2Q38348366-5EC2526B-6E3F-4FAC-9C41-93B16F9ACC36Q39687901-79009E70-0939-4796-AEF1-FE1C8F1038FEQ44516010-D7E53592-4909-41F0-9F4A-4DE2363603E5Q45717356-C790EDB1-6E34-4C81-8C01-E6889F49C594Q45956921-0BB27EAE-3BD7-4427-B602-74031C5F90EEQ51607250-81257601-80A7-40E8-B029-8D0913B7132AQ56700247-3A9453BF-C488-452B-8AB5-3DB8E6287201Q56992527-1D443F66-39E9-4184-8CC0-4D343FD44758Q57086524-D8A86E84-3390-40AF-87A2-83A318A705A8Q57905710-E64618E4-91C7-4043-8F2A-F5AC2ADF2AE2
P2860
How is disease progress in Friedreich's ataxia best measured? A study of four rating scales.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
How is disease progress in Fri ...... A study of four rating scales.
@ast
How is disease progress in Fri ...... A study of four rating scales.
@en
type
label
How is disease progress in Fri ...... A study of four rating scales.
@ast
How is disease progress in Fri ...... A study of four rating scales.
@en
prefLabel
How is disease progress in Fri ...... A study of four rating scales.
@ast
How is disease progress in Fri ...... A study of four rating scales.
@en
P2093
P2860
P356
P1476
How is disease progress in Fri ...... A study of four rating scales
@en
P2093
A J Churchyard
M B Delatycki
P2860
P304
P356
10.1136/JNNP.2006.096008
P407
P577
2006-10-20T00:00:00Z